thx , thats all I found also , guess pres.weekend was my questimate, The question now is how far can they go with current funding? The commercialization burn rate is a big question to me. It appears they have funding in place for a couple/few quarters so we need to see a fast ramp to revenues. Will they/can they use debt or will the dilute and when is a big question as is production of device.
from the technical side I see and understand. I tend to be more of a fundamentalist and am/ was looking from that side. Any thoughts on CGIX as a business ? I feel the patents and tests have strong revenue potential.
With current volume and pricing that's evident , my question is why ? Volume is extremely high for such a modest float , taking into consideration the almost doubling of float in the past weeks and the current warrant overhang.
after listening to last CC . That some analyst would have picked up on QFOR . No article , comment , etc. anywhere that I have found. Very strange . Any one hear or see anything positive or negative in the financial world regarding QFOR since the CC ?
thx , that is/was pretty much my take. Frost not just absorbing it into OPKO prior to the merger is very odd since it had revenues with additional u.s. revenue potential in 2016. Instead chose to use revenues to fund current merged pipeline , perhaps sum of parts is greater than whole when looking for current/future funding opportunities. Agree , Patience is operative phrase.
remember they were in bankruptcy court , I think they got more than they thought and just want to get it behind them. I do not recall any restrictions other than normal closing ones. I would be surprised if court allowed any.
I'm beginning to sense the end of the volume selling created by the stock portion of the rdgx asset purchase and the accompanied tax loss/shorting season. The current down draft should begin to stabilize and pps should start to rise soon. Nobody should be surprised that the custodians sold the stock portion to raise cash. The equity offering proved MM want involvement in CGIX and the sale by the custodians afforded all a great way to purchase stock on the cheap. IMO
HOSED ? Correct me if I'm wrong but wasn't RGDX purchased from/in the bankruptcy courts ? I'm not sure regarding restrictions but I do not recall any and think that is what is effecting the current stock price.
consider it a christmas gift , prime angus selling at choice prices , a 50-75% off sale. whatever. Anything can happen but the future looks bright, time to put on the shades is fast approaching, fundamentally , technically and realistically. I remember somebody once saying the market can stay irrational longer than most investors can stay long. GL
ISIS pumps oil in Iraq ships it to refineries in syria and sells it on the market for over $500 million a year and we do what? Its all broken try to grab a chair before the music stops and always wear protection. GL
nice pipeline, revenues , deep pocketed backers, etc. etc. it has been taken to the wood shed and trashed. When will management get out in front and stop the carnage ???????? Strange that Frost has allowed management to stay so docile and quiet. Was the private to public change just a payday for old regime/owners ? Frost could have bought it outrite for pocket change and enveloped it into OPKO, IMO.
Strange very strange
or shorted by Gunnar only to be bought back next month further reducing their cost basis and increasing their profit ? A favorite Goldman strategy.......
I liked the Q & A question , I paraphrase , ' Do you have a comment on why QFOR has revenues over $50 million and growing and a market cap of only $20 million ? Don't most disruptive , young , growing tech co. have market caps at multiples of revenue ? If management can deliver on what they said the PPS of QFOR should get to $1 fairly quickly , one well placed article , one deep pocketed investor , one analyst , etc. etc . and away it goes.......................
CGIX sells / dilutes aprox. 50% of stock to some heavy weight investors for $3.70+ ps adj. for comm. and warrants for $5. ps. Announce they will be approaching positive cash flow position within year, which should enable debt raising vs dilution if cash needed. State they have enough cash for 1-2 years. Revenues are growing. Insurance coding and reimbursement is accelerating. Insurance companies , Biopharmas , hospitals , leading cancer institutes and Doctors are all involved or will be as insurance companies start to sign on , the float is small and a large % is held by insiders or big investors at prices ranging from $4 - $14 and the stock continues to sell off. Interesting , very INTERESTING...